MacDonald James J.'s Form 4 filing
Sana Biotechnology, Inc.SANA · filed Feb 23, 2022
- Accession no.
- 0001562180-22-001784
- Filed
- Feb 23, 2022
- Trade date
- Nov 15, 2021-Feb 18, 2022
- Filing delay
- 100 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $2.09K. It was filed 100 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| MacDonald James J.CIK 0001830054 | Officer (EVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Common Stock | AGrant or awardAcquired | +1,000 | $18.23F2 | +$18,230 | 429,750 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −333 | $6.28 | −$2,091.24 | 429,417 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021.
Referenced by the price of 1 transaction in Table I.